Direct-to-consumer DNA testing firm 23andMe Holding Co. said on Friday it would buy privately held company Lemonaid Health Inc. for $400 million in a cash-and-stock deal, as it looks to expand into telemedicine. Lemonaid Health offers patients direct online access …
from News – Insurance Journal https://ift.tt/3CcD5IB
via
IFTTT
No comments:
Post a Comment